•  Nasdaq

  •  OTC BB


    ProPhase Labs (PRPH) Rejected the Revised and Unsolicited Non-Binding Proposal from Matrixx Initiatives to Be Acquired for $1.60 per Share

    October 29 Oct 2012 | 13:02


    http://pennyomega.com/img/prph.jpg PRPH, ProPhase Labs, Inc.

    ** PRPH reported that it has rejected the revised and unsolicited, non-binding proposal from Matrixx Initiatives, Inc. (“Matrixx”) to acquire the Company for $1.60 per share in cash.

    This most recent proposal, like their prior $1.40 per share proposal, is conditioned on further due diligence by Matrixx.


    PRPH is a diversified natural health medical science company. It is a leading marketer of the Cold-EEZE(R) Cold Remedy brand as well as other cold relief products.

    More about PRPH at www.ProPhaseLabs.com.


    Read Full Disclaimer at http://CRWENews.com/disclaimer

    Tags: , ,



      Exclusive Video
  • EQCO2, Inc. Fraud Lawsuit

  • Hot stocks to watch!

    Direxion Shs Etf Tr - TZA

    Las Vegas Sands Corp - LVS

    Marshall & Ilsley Corp - MI

    Directv - DTV

    Urban Outfitters Inc - URBN

    NetApp Inc - NTAP

    Financial Select Sector SPDR ETF - XLF

    Huntington Bancshares Inc - HBAN

    Crown Equity Holdings Inc. - CRWE

    iShares Silver Trust ETF - SLV

    Activision Blizzard Inc - ATVI

    Apple Inc - AAPL

    iShares Russell 2000 Index Fund - IWM

    JA Solar Holdings Co Ltd - JASO

    Comcast Corp New - CMCSA

    Weatherford Internation Lt - WFT

    iShares MSCI EAFE Index ETF - EFA

    Regions Financial Corp - RF

    SPDR Gold Trust ETF - GLD

    PowerShares QQQ - QQQQ

    Kingdom Koncrete Inc. - KGKO

    JPMorgan Chase & Co - JPM

     CRWE Network